IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
608.41
-10.51 (-1.70%)
At close: Mar 6, 2026, 4:00 PM EST
606.48
-1.93 (-0.32%)
After-hours: Mar 6, 2026, 6:29 PM EST
IDEXX Laboratories Revenue
In the year 2025, IDEXX Laboratories had annual revenue of $4.30B with 10.42% growth. IDEXX Laboratories had revenue of $1.09B in the quarter ending December 31, 2025, with 14.28% growth.
Revenue (ttm)
$4.30B
Revenue Growth
+10.42%
P/S Ratio
11.26
Revenue / Employee
$391,246
Employees
11,000
Market Cap
48.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.30B | 406.20M | 10.42% |
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
| Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
| Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
| Dec 31, 2018 | 2.21B | 244.18M | 12.40% |
| Dec 31, 2017 | 1.97B | 193.64M | 10.91% |
| Dec 31, 2016 | 1.78B | 173.53M | 10.83% |
| Dec 31, 2015 | 1.60B | 116.09M | 7.81% |
| Dec 31, 2014 | 1.49B | 108.75M | 7.90% |
| Dec 31, 2013 | 1.38B | 83.72M | 6.47% |
| Dec 31, 2012 | 1.29B | 74.65M | 6.13% |
| Dec 31, 2011 | 1.22B | 115.30M | 10.45% |
| Dec 31, 2010 | 1.10B | 71.76M | 6.96% |
| Dec 31, 2009 | 1.03B | 7.60M | 0.74% |
| Dec 31, 2008 | 1.02B | 101.48M | 11.00% |
| Dec 31, 2007 | 922.56M | 183.44M | 24.82% |
| Dec 31, 2006 | 739.12M | 101.02M | 15.83% |
| Dec 31, 2005 | 638.10M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thermo Fisher Scientific | 44.56B |
| Danaher | 24.57B |
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| Mettler-Toledo International | 4.03B |
IDXX News
- 2 days ago - Baron Growth Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 4 days ago - IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript - Seeking Alpha
- 8 days ago - IDEXX Laboratories, Inc. (IDXX) Presents at BofA Securities Animal Health Summit Transcript - Seeking Alpha
- 17 days ago - Baron Partners Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 22 days ago - IDEXX Laboratories to Present at Two Institutional Investor Conferences - Business Wire
- 4 weeks ago - IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results - Benzinga
- 4 weeks ago - IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics - Reuters